ALBA MANUEL 4

Accession 0001134727-25-000006

CIK 0001736297other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 7:32 PM ET

Size

46.1 KB

Accession

0001134727-25-000006

Insider Transaction Report

Form 4

Period: 2025-12-01

Astera Labs, Inc.ALAB

ALBA MANUEL

Director

Transactions

Sale
Common Stock
2025-12-01$153.80/sh−4,504$692,698→ 1,719,994 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$154.74/sh−3,232$500,136→ 1,716,762 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$155.50/sh−1,062$165,139→ 1,715,700 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$156.88/sh−807$126,599→ 1,714,893 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$158.11/sh−425$67,196→ 1,714,468 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$159.29/sh−963$153,399→ 1,713,505 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$160.54/sh−1,068$171,455→ 1,712,437 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$161.63/sh−4,076$658,804→ 1,708,361 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$162.52/sh−2,322$377,375→ 1,706,039 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$163.68/sh−10,732$1,756,584→ 1,695,307 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$164.60/sh−12,468$2,052,256→ 1,682,839 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$165.39/sh−38,644$6,391,513→ 1,644,195 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$166.67/sh−12,868$2,144,676→ 1,631,327 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$167.52/sh−11,158$1,869,219→ 1,620,169 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$168.57/sh−4,582$772,375→ 1,615,587 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$169.84/sh−8,872$1,506,863→ 1,606,715 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$170.63/sh−13,722$2,341,346→ 1,592,993 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$171.57/sh−12,186$2,090,812→ 1,580,807 total(indirect: By Trust)
Sale
Common Stock
2025-12-01$172.57/sh−6,309$1,088,776→ 1,574,498 total(indirect: By Trust)

Holdings

Common Stock
(indirect: By LLC)
385,863
Common Stock
(indirect: By Spouse)
5,000
Common Stock
2,351

Footnotes (22)

[F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025.
[F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.0600 to $162.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F11]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.1100 to $163.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F12]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.1100 to $164.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F13]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.1300 to $165.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F14]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.1300 to $166.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F15]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.1300 to $167.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F16]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.1300 to $168.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F17]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.1300 to $169.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F18]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.1400 to $170.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F19]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.1400 to $171.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.0700 to $154.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F20]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.1400 to $172.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F21]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.1400 to $173.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F22]These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
[F3]These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
[F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.2300 to $155.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.3300 to $156.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.3900 to $157.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.7700 to $158.3400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.9100 to $159.8900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.0600 to $161.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

4
wk-form4_1764808355.xmlPrimary
FORM 4

Issuer

Astera Labs, Inc.

CIK 0001736297

→

Entity typeother

Related Parties

filerCIK 0001134727

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 7:32 PM ET
Size: 46.1 KB

View on SEC.gov